Subacute Manganese Exposure in Rats is a Neurochemical Model of Early Manganese Toxicity

Overview

Journal Neurotoxicology

Specialties Environmental Health
Neurology
Toxicology

Date 2014 Aug 14

PMID 25117542

Citations 25

Authors

Stefanie L ONeal

Jang-Won Lee

Wei Zheng

Jason R Cannon

Affiliations

Soon will be listed here.

Abstract

Manganese (Mn) is an essential trace element, but excess exposure leads to accumulation in biological tissues, including the brain. Chronically high Mn levels in the brain are neurotoxic and can result in a progressive, irreversible neurological disorder known as manganism. Manganism has signs and symptoms similar to, but distinguishable from idiopathic Parkinson's disease, which include both psychological and motor disturbances. Evidence suggests that Mn exposure impacts neurotransmitter levels in the brain. However, it remains unclear if subacute, low-level Mn exposure resulted in alterations in neurotransmitter systems with concomitant behavioral deficits. The current study used high performance liquid chromatography to quantify neurotransmitter levels in rat striatum (STR), substantia nigra (SN), and hippocampus (HP). Subacute Mn exposure via i.p. injection of 15mg Mn/kg as MnCl2 caused significantly increased dopamine (DA) levels in the STR. The enhancement was accompanied by significantly elevated levels of the DA metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), in the STR. In addition, levels of HVA were significantly increased in the SN and HP. These data indicate that subacute, low-level Mn exposure disrupts multiple neurotransmitter systems in the rat brain which may be responsible, in part, for observed locomotor deficits.

Citing Articles

Manganese Overexposure Alters Neurogranin Expression and Causes Behavioral Deficits in Larval Zebrafish.

Alba-Gonzalez A, Dragomir E, Haghdousti G, Yanez J, Dadswell C, Gonzalez-Mendez R Int J Mol Sci. 2024; 25(9).

PMID: 38732149 PMC: 11084468. DOI: 10.3390/ijms25094933.

Neuroprotective Effect of Resveratrol against Manganese-Induced Oxidative Stress and Matrix Metalloproteinase-9 in an "In Vivo" Model of Neurotoxicity.

Latronico T, Rossano R, Miniero D, Casalino E, Liuzzi G Int J Mol Sci. 2024; 25(4).

PMID: 38396818 PMC: 10888573. DOI: 10.3390/ijms25042142.

An Industry-Relevant Metal Mixture, Iron Status, and Reported Attention-Related Behaviors in Italian Adolescents.

Schildroth S, Kordas K, White R, Friedman A, Placidi D, Smith D Environ Health Perspect. 2024; 132(2):27008.

PMID: 38363634 PMC: 10871126. DOI: 10.1289/EHP12988.

Trace Metal Accumulation in Rats Exposed to Mine Waters: A Case Study, Bor Area (Serbia).

Caraba I, Caraba M, Hutanu D, Sinitean A, Dumitrescu G, Popescu R Toxics. 2023; 11(12).

PMID: 38133361 PMC: 10748338. DOI: 10.3390/toxics11120960.

Assessing the mediating role of iron status on associations between an industry-relevant metal mixture and verbal learning and memory in Italian adolescents.

Schildroth S, Valeri L, Kordas K, Shi B, Friedman A, Smith D Sci Total Environ. 2023; 906:167435.

PMID: 37774885 PMC: 10918745. DOI: 10.1016/j.scitotenv.2023.167435.

References

Ou C, Huang M, Jiang Y, Luo H, Deng X, Wang C . [Effect of sodium para-aminosalicylic on concentrations of amino acid neurotransmitters in basal ganglia of manganese-exposed rats]. Zhonghua Yu Fang Yi Xue Za Zhi. 2011; 45(5):422-5. View

CHANDRA S, Shukla G . Concentrations of striatal catecholamines in rats given manganese chloride through drinking water. J Neurochem. 1981; 36(2):683-7. DOI: 10.1111/j.1471-4159.1981.tb01642.x. View

Vezer T, Kurunczi A, Naray M, Papp A, Nagymajtenyi L . Behavioral effects of subchronic inorganic manganese exposure in rats. Am J Ind Med. 2007; 50(11):841-52. DOI: 10.1002/ajim.20485. View

Husain M, Khanna V, Roy A, Tandon R, Pradeep S, Set P . Platelet dopamine receptors and oxidative stress parameters as markers of manganese toxicity. Hum Exp Toxicol. 2002; 20(12):631-6. DOI: 10.1191/096032701718890531. View

Cannon J, Tapias V, Na H, Honick A, Drolet R, Greenamyre J . A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis. 2009; 34(2):279-90. PMC: 2757935. DOI: 10.1016/j.nbd.2009.01.016. View

Pothos E, Hernandez L, Hoebel B . Chronic food deprivation decreases extracellular dopamine in the nucleus accumbens: implications for a possible neurochemical link between weight loss and drug abuse. Obes Res. 1995; 3 Suppl 4:525S-529S. DOI: 10.1002/j.1550-8528.1995.tb00222.x. View

Nachtman J, Tubben R, Commissaris R . Behavioral effects of chronic manganese administration in rats: locomotor activity studies. Neurobehav Toxicol Teratol. 1986; 8(6):711-5. View

Mergler D, Baldwin M, Belanger S, Larribe F, Beuter A, Bowler R . Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology. 1999; 20(2-3):327-42. View

Aschner M, Vrana K, Zheng W . Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology. 1999; 20(2-3):173-80. View

10.

COTZIAS G, PAPAVASILIOU P, Mena I, Tang L, Miller S . Manganese and catecholamines. Adv Neurol. 1974; 5:235-43. View

11.

Dodd C, Bloomquist J, Klein B . Consequences of manganese administration for striatal dopamine and motor behavior in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed C57BL/6 mice. Hum Exp Toxicol. 2012; 32(8):865-80. DOI: 10.1177/0960327112469043. View

12.

Bowman A, Kwakye G, Herrero Hernandez E, Aschner M . Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol. 2011; 25(4):191-203. PMC: 3230726. DOI: 10.1016/j.jtemb.2011.08.144. View

13.

Cannon J, Geghman K, Tapias V, Sew T, Dail M, Li C . Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment. Exp Neurol. 2012; 240:44-56. PMC: 3552027. DOI: 10.1016/j.expneurol.2012.11.007. View

14.

Robison G, Zakharova T, Fu S, Jiang W, Fulper R, Barrea R . X-ray fluorescence imaging: a new tool for studying manganese neurotoxicity. PLoS One. 2012; 7(11):e48899. PMC: 3501493. DOI: 10.1371/journal.pone.0048899. View

15.

CHANDRA S, Shukla G, Saxena D . Manganese-induced behavioral dysfunction and its neurochemical mechanism in growing mice. J Neurochem. 1979; 33(6):1217-21. DOI: 10.1111/j.1471-4159.1979.tb05267.x. View

16.

Dobson A, Erikson K, Aschner M . Manganese neurotoxicity. Ann N Y Acad Sci. 2004; 1012:115-28. DOI: 10.1196/annals.1306.009. View

17.

Wang Y, Lee J, Oh G, Grady S, McIntosh J, Brunzell D . Enhanced synthesis and release of dopamine in transgenic mice with gain-of-function α6* nAChRs. J Neurochem. 2013; 129(2):315-27. PMC: 3980028. DOI: 10.1111/jnc.12616. View

18.

Guilarte T . Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect. 2010; 118(8):1071-80. PMC: 2920085. DOI: 10.1289/ehp.0901748. View

19.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

20.

Roth J . Are there common biochemical and molecular mechanisms controlling manganism and parkisonism. Neuromolecular Med. 2009; 11(4):281-96. DOI: 10.1007/s12017-009-8088-8. View